search
Back to results

Evaluation of the OsciPulse Rapid Cycling Compression Device Effects on Venous Blood Flow

Primary Purpose

Venous Thromboses, Venous Stasis

Status
Completed
Phase
Early Phase 1
Locations
United States
Study Type
Interventional
Intervention
OsciPulse system
Reference Therapy 1
Refence Therapy 2
Sponsored by
OsciFlex LLC
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Venous Thromboses focused on measuring Venous compression, Intermittent pneumatic compression

Eligibility Criteria

40 Years - 90 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Adult age ≥40 years old
  • Generally healthy.
  • No history of diagnosed vascular disease including: DVT, PE, VTE, peripheral vascular disease, post-phlebitic syndrome, or chronic venous insufficiency.
  • Mentally alert and understand English proficiently.
  • Able to give informed consent.

Exclusion Criteria:

  • Skin breaks, abrasion, or irritation in the area of the limb in contact with the OsciPulse device or reference therapies.
  • Severe peripheral artery or venous disease.

Sites / Locations

  • University of Pennsylvania

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Study arm

Arm Description

In this single arm study all enrolled subjects will the intervention by the investigational device, and both reference devices. Ultrasound will be used to measure the blood flow in the subject during the use of all three devices.

Outcomes

Primary Outcome Measures

Venous valve sinus forward flow volume index
The volume flow index (mL/mL) will be measured for flow in the valve sinus region that is moving back towards the heart (forward flow). The venous flow at a valve will be measured using 2D color Doppler ultrasound, and flow volume index calculated from the resulting video clips.
Venous valve sinus reversing flow volume index
The volume flow index (mL/mL) will be measured for flow in the valve sinus region that is moving away from the heart (reversing flow). The venous flow at a valve will be measured using 2D color Doppler ultrasound, and flow volume index calculated from the resulting video clips.
Deep vein centerline flow
The velocity of venous flow measured by spectral Doppler ultrasound in the deep femoral vein.
Venous valve sinus rouleaux
The degree of red blood cell rouleaux in the sinus of venous valves will be measured using B-mode ultrasound.

Secondary Outcome Measures

Full Information

First Posted
September 28, 2021
Last Updated
August 7, 2023
Sponsor
OsciFlex LLC
Collaborators
University of Pennsylvania, National Heart, Lung, and Blood Institute (NHLBI)
search

1. Study Identification

Unique Protocol Identification Number
NCT05087108
Brief Title
Evaluation of the OsciPulse Rapid Cycling Compression Device Effects on Venous Blood Flow
Official Title
A Crossover Study of the Hemodynamic Effect of the OsciPulse Device Compared to Reference Therapies
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Completed
Study Start Date
March 17, 2022 (Actual)
Primary Completion Date
June 30, 2022 (Actual)
Study Completion Date
June 30, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
OsciFlex LLC
Collaborators
University of Pennsylvania, National Heart, Lung, and Blood Institute (NHLBI)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study will evaluate the effects on venous blood flow of the investigational device, OsciPulse system, which is an external intermittent limb compression device. The study will enroll healthy human subjects who will have their deep venous blood flow measured by vascular ultrasound during immobility, use of the OsciPulse system, and use of two reference vascular compression devices. Our hypothesis is that the OsciPulse system will create distinct patterns of venous flow, specifically at the site of venous valves, in comparison to the reference compression devices.
Detailed Description
Enrolled healthy subjects will undergo and initial vascular ultrasound imaging procedure to locate a deep venous valve in either the sapheno-femoral junction or femoral trifurcation sites. Once the imaging valve is identified the baseline level of venous flow will be collected in 30 s video clips of 2D color Doppler videos and spectral Doppler. Next, either the OsciPulse device, or one of the two reference therapy devices, will be applied by study personnel according to the device's specific instructions. The subject will wear the device during the capture of 1 spectral Doppler clip and three 30 s 2D color Doppler ultrasound clips on both the left and right leg. Next, the remaining two devices will be applied based on instructions, and vascular ultrasound clips captured for each. Completion of this visit protocol will be the end of the study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Venous Thromboses, Venous Stasis
Keywords
Venous compression, Intermittent pneumatic compression

7. Study Design

Primary Purpose
Basic Science
Study Phase
Early Phase 1
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
16 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Study arm
Arm Type
Experimental
Arm Description
In this single arm study all enrolled subjects will the intervention by the investigational device, and both reference devices. Ultrasound will be used to measure the blood flow in the subject during the use of all three devices.
Intervention Type
Device
Intervention Name(s)
OsciPulse system
Intervention Description
The OsciPulse system is an intermittent pneumatic limb compression system. The OsciPulse sleeves that are applied to the top portion of the user's calves and are periodically inflated with rapid bursts of compressed air to create frequent pulses of venous return.
Intervention Type
Device
Intervention Name(s)
Reference Therapy 1
Other Intervention Name(s)
Venaflow Elite Vascular System
Intervention Description
The Venaflow Elite is a sequential compression device that uses compressed air to inflate sleeves worn on the calf of the user to stimulate venous return. The Venaflow system sleeves cover the entire calf region of the user and contain two bladders that are inflated sequentially to induce venous return.
Intervention Type
Device
Intervention Name(s)
Refence Therapy 2
Other Intervention Name(s)
Kendall 700 Series SCD
Intervention Description
The Kendall SCD device is a sequential compression device that uses compressed air to inflate sleeves worn on the calf of the user to stimulate venous return. The Kendall SCD sleeves cover the entire calf region of the user and contain three bladders that are inflated sequentially to induce venous return.
Primary Outcome Measure Information:
Title
Venous valve sinus forward flow volume index
Description
The volume flow index (mL/mL) will be measured for flow in the valve sinus region that is moving back towards the heart (forward flow). The venous flow at a valve will be measured using 2D color Doppler ultrasound, and flow volume index calculated from the resulting video clips.
Time Frame
Visit 1 - 60 minutes
Title
Venous valve sinus reversing flow volume index
Description
The volume flow index (mL/mL) will be measured for flow in the valve sinus region that is moving away from the heart (reversing flow). The venous flow at a valve will be measured using 2D color Doppler ultrasound, and flow volume index calculated from the resulting video clips.
Time Frame
Visit 1 - 60 minutes
Title
Deep vein centerline flow
Description
The velocity of venous flow measured by spectral Doppler ultrasound in the deep femoral vein.
Time Frame
Visit 1 - 60 minutes
Title
Venous valve sinus rouleaux
Description
The degree of red blood cell rouleaux in the sinus of venous valves will be measured using B-mode ultrasound.
Time Frame
Visit 1 - 60 minutes

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Adult age ≥40 years old Generally healthy. No history of diagnosed vascular disease including: DVT, PE, VTE, peripheral vascular disease, post-phlebitic syndrome, or chronic venous insufficiency. Mentally alert and understand English proficiently. Able to give informed consent. Exclusion Criteria: Skin breaks, abrasion, or irritation in the area of the limb in contact with the OsciPulse device or reference therapies. Severe peripheral artery or venous disease.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
John Welsh, PhD
Organizational Affiliation
OsciFlex LLC
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Chandra Sehgal, PhD
Organizational Affiliation
University of Pennsylvania
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Pennsylvania
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19146
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Our plan is to make available for sharing all IPD that underlie results in a publication.
IPD Sharing Time Frame
The data will become available starting 6 months after publication of the study and will be available for 24 months upon request.
IPD Sharing Access Criteria
Qualifying IPD will be shared with specific requestors if they are at an academic or government institution and to be used for non-commercial research. Requests will be evaluated by OsciFlex LLC.

Learn more about this trial

Evaluation of the OsciPulse Rapid Cycling Compression Device Effects on Venous Blood Flow

We'll reach out to this number within 24 hrs